<DOC>
	<DOC>NCT01855165</DOC>
	<brief_summary>Drug-drug interactions (DDIs) are common in patients with chronic heart failure (CHF) and their incidence increases with the number of drugs that the patients are prescribed for treatment of their condition. Data bases often detect DDIs that are of high clinical relevance. The investigators have performed this study in order to detect clinically significant DDIs and to diminish their occurrence by sending notification about DDIs to attending physician.</brief_summary>
	<brief_title>The Role of Clinical Pharmacist in Management of DDIs in CHF Patients</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients admitted with diagnosis of CHF I50.0 I50.9 and I11.0 I11.9 (ICD10) patients treated with at least two drugs Patients admitted to other conditions</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>chronic heart failure</keyword>
	<keyword>drug-drug interactions</keyword>
	<keyword>pharmacist's intervention</keyword>
</DOC>